PETROS GEORGE NIKOLINAKOS M.D. NPI 1306041900

NPI Details

Petros George Nikolinakos, M.D. is a hematology and oncology internal medicine in Athens, GA with 29 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Petros George Nikolinakos, M.D. NPI is 1306041900. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

3320 OLD JEFFERSON RD BLDG 800
ATHENS, GA
ZIP 30607-400
Phone: (706) 353-2990
Fax: (706) 353-2992

The NPI 1306041900 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, oxaliplatin, 0.5 mg (HCPCS:J9263)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, aprepitant, 1 mg (HCPCS:J0185)
• Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS:J9144)
• Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS:J0885)
• Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1568)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Injection, atropine sulfate, 0.01 mg (HCPCS:J0461)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Injection, rituximab-arrx, biosimilar, (riabni), 10 mg (HCPCS:Q5123)
• Lutetium lu 177 vipivotide tetraxetan, therapeutic, 1 millicurie (HCPCS:A9607)
• Uric acid level, blood (HCPCS:84550)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
• Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
• Injection, irinotecan, 20 mg (HCPCS:J9206)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
• Ferritin (blood protein) level (HCPCS:82728)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Radiopharmaceutical, therapeutic, not otherwise classified (HCPCS:A9699)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Magnesium level (HCPCS:83735)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Folic acid level, serum (HCPCS:82746)
• Red blood count, automated test (HCPCS:85045)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or (HCPCS:G2212)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Injection, fosnetupitant 235 mg and palonosetron 0.25 mg (HCPCS:J1454)
• Cortisol (hormone) measurement, total (HCPCS:82533)
• Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Blood test, basic group of blood chemicals (calcium, ionized) (HCPCS:80047)
• Liver function blood test panel (HCPCS:80076)
• Unclassified drugs (HCPCS:J3490)
• Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
• Ct scan of chest with contrast (HCPCS:71260)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Nephelometry, test method using light (HCPCS:83883)
• Application of on-body injector for under skin injection (HCPCS:96377)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9 (HCPCS:86301)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• Injection of drug or substance into vein (HCPCS:96374)
• Administration of prolonged chemotherapy into vein (HCPCS:96416)
• Urinalysis, manual test (HCPCS:81002)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Ct scan of chest without contrast (HCPCS:71250)
• Lipase (fat enzyme) level (HCPCS:83690)
• Thyroid hormone, t3 measurement, free (HCPCS:84481)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Amylase (enzyme) level (HCPCS:82150)
• Radioactive drug therapy through a vein (HCPCS:79101)
• Drawing of blood for a medical problem (HCPCS:99195)
• Administration of chemotherapy into vein using push technique (HCPCS:96409)
• Phosphate level (HCPCS:84100)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Ct scan of abdomen and pelvis without contrast (HCPCS:74176)
• Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Telephone medical discussion with physician, 21-30 minutes (HCPCS:99443)
• Blood creatinine level (HCPCS:82565)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Vitamin d-3 level (HCPCS:82306)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Influenza vaccine split virus, preservative free (HCPCS:90662)
• Biopsy and aspiration of bone marrow sample for diagnosis (HCPCS:38222)

The enumeration date for this NPI number is 6/15/2007 and was last updated on 7/19/2024.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.